tradingkey.logo
搜索

Enanta Pharmaceuticals Inc

ENTA
添加自选
12.600USD
-0.400-3.08%
收盘 07-31 16:00美东报价延迟15分钟
366.39M总市值
亏损市盈率 TTM

ENTA 财务数据

通过专为投资者打造的一站式数据看板,全面查看 Enanta Pharmaceuticals Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。

Enanta Pharmaceuticals Inc财报日历

最新发布
8月 10, 2026
每股收益 / 预测值
--/-0.51
营业收入 / 预测值
--/16.80M
报告期
FY2025 财报
营业收入(YoY)
65.32M
-3.42%
每股收益(YoY)
-3.84
30.03%
分析师评级
BUY
2026/08/02
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
57.49%-0.45
60.43%-0.42
35.68%-0.87
20.17%-0.85
27.96%-1.06
33.75%-1.05
-1.90%-1.36
42.34%-1.07
17.78%-1.47
-13.77%-1.58
---1.33
---1.86
---1.79
---1.39
----
----
----
----
----
----
营业收入
14.96%17.16M
9.76%18.61M
3.55%15.13M
1.91%18.31M
-12.48%14.93M
-5.80%16.96M
-22.84%14.61M
-4.88%17.97M
-4.16%17.05M
-23.67%18.00M
-6.82%18.93M
-3.01%18.89M
-4.92%17.80M
-14.70%23.59M
-13.82%20.32M
-9.92%19.48M
-7.03%18.72M
-12.90%27.65M
-0.24%23.57M
15.93%21.62M
净利润
42.19%-13.09M
46.44%-11.94M
35.12%-18.70M
19.43%-18.25M
27.32%-22.64M
33.28%-22.29M
-2.55%-28.82M
42.00%-22.66M
17.26%-31.16M
-15.25%-33.41M
-6.68%-28.11M
-23.23%-39.06M
-12.10%-37.66M
3.75%-28.99M
-7.11%-26.35M
-31.95%-31.70M
-52.38%-33.59M
-261.61%-30.11M
16.16%-24.60M
-68.41%-24.02M
利润率
49.71%-76.29%
51.21%-64.13%
37.34%-123.64%
20.94%-99.68%
16.96%-151.71%
29.17%-131.43%
-32.91%-197.32%
39.03%-126.08%
13.67%-182.70%
-50.99%-185.56%
---148.46%
---206.78%
---211.62%
---122.90%
----
----
----
----
----
----
毛利率
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
----
资产负债率
9789.32%41.33%
10568.06%41.31%
14127.10%50.99%
25.69%0.45%
21.47%0.42%
16.60%0.39%
16.43%0.36%
24.16%0.36%
-21.06%0.34%
-18.90%0.33%
--0.31%
--0.29%
--0.44%
--0.41%
----
----
----
----
----
----
营业收入
14.96%17.16M
9.76%18.61M
3.55%15.13M
1.91%18.31M
-12.48%14.93M
-5.80%16.96M
-22.84%14.61M
-4.88%17.97M
-4.16%17.05M
-23.67%18.00M
-6.82%18.93M
-3.01%18.89M
-4.92%17.80M
-14.70%23.59M
-13.82%20.32M
-9.92%19.48M
-7.03%18.72M
-12.90%27.65M
-0.24%23.57M
15.93%21.62M
营业利润
51.68%-11.85M
52.20%-11.25M
38.41%-18.39M
21.88%-18.89M
25.14%-24.53M
32.51%-23.54M
3.79%-29.85M
34.12%-24.18M
16.95%-32.77M
-16.24%-34.89M
-14.72%-31.03M
-12.82%-36.71M
-16.56%-39.45M
1.30%-30.01M
19.80%-27.05M
3.86%-32.54M
-13.96%-33.85M
-147.25%-30.41M
-70.48%-33.73M
-48.11%-33.85M
净利润
42.19%-13.09M
46.44%-11.94M
35.12%-18.70M
19.43%-18.25M
27.32%-22.64M
33.28%-22.29M
-2.55%-28.82M
42.00%-22.66M
17.26%-31.16M
-15.25%-33.41M
-6.68%-28.11M
-23.23%-39.06M
-12.10%-37.66M
3.75%-28.99M
-7.11%-26.35M
-31.95%-31.70M
-52.38%-33.59M
-261.61%-30.11M
16.16%-24.60M
-68.41%-24.02M
流动资产
-26.54%178.41M
-25.90%198.68M
-31.85%204.34M
-22.29%222.71M
-30.81%242.86M
-31.30%268.14M
-29.08%299.85M
-36.10%286.58M
29.47%351.03M
37.57%390.30M
35.63%422.79M
43.26%448.46M
-20.69%271.14M
-13.23%283.70M
-2.29%311.71M
-2.53%313.04M
-20.16%341.87M
-26.68%326.96M
-26.97%319.02M
-22.31%321.15M
流动负债总额
1.08%46.44M
-8.81%44.73M
-15.61%48.55M
-26.04%44.55M
-15.86%45.95M
-21.40%49.05M
-8.36%57.53M
-11.66%60.24M
69.77%54.61M
171.32%62.41M
110.50%62.79M
196.02%68.19M
4.65%32.17M
-39.30%23.00M
-17.54%29.83M
-19.53%23.04M
15.48%30.74M
64.42%37.89M
49.74%36.17M
19.70%28.62M
总资产
-2.57%314.70M
-5.49%329.50M
-25.47%280.73M
-24.52%301.03M
-21.90%322.99M
-18.64%348.64M
-18.52%376.65M
-19.46%398.82M
26.69%413.56M
23.30%428.50M
23.14%462.27M
28.54%495.17M
-19.76%326.44M
-21.12%347.53M
-14.44%375.41M
-14.48%385.21M
-13.03%406.82M
-8.40%440.59M
-9.74%438.79M
-11.97%450.44M
总负债
-13.66%198.12M
-14.32%202.91M
-12.84%216.01M
-11.97%221.75M
-7.27%229.46M
0.09%236.83M
0.94%247.84M
-2.11%251.91M
333.58%247.44M
406.70%236.62M
354.06%245.54M
445.34%257.35M
18.32%57.07M
-16.92%46.70M
37.38%54.08M
44.82%47.19M
51.99%48.23M
93.71%56.21M
28.84%39.36M
4.62%32.59M
总权益
24.64%116.59M
13.21%126.59M
-49.76%64.72M
-46.76%79.28M
-43.69%93.54M
-41.73%111.82M
-40.57%128.81M
-37.38%148.91M
-38.33%166.11M
-36.22%191.88M
-32.55%216.74M
-29.64%237.82M
-24.88%269.38M
-21.74%300.84M
-19.55%321.33M
-19.10%338.02M
-17.76%358.58M
-14.96%384.38M
-12.33%399.43M
-13.05%417.85M
经营净额
46.95%-7.16M
30.37%-11.70M
37.61%-6.49M
218.48%17.51M
52.84%-13.49M
32.76%-16.80M
51.86%-10.40M
54.01%-14.78M
-107.51%-28.60M
29.89%-24.99M
-39.06%-21.60M
-8.53%-32.13M
47.74%-13.78M
-168.56%-35.64M
26.10%-15.53M
-0.33%-29.60M
-476.00%-26.38M
10.87%-13.27M
-35.96%-21.02M
-557.44%-29.51M
投资净额
373.33%11.94M
-168.64%-47.30M
-87.96%2.30M
-317.38%-26.48M
-107.45%-4.37M
625.30%68.90M
61.14%19.07M
95.65%-6.34M
25.36%58.62M
-139.07%-13.12M
-58.07%11.84M
-998.57%-145.75M
233.40%46.77M
-26.22%33.57M
-61.16%28.23M
137.11%16.22M
-237.70%-35.05M
360.83%45.50M
2802.68%72.68M
-263.21%-43.70M
融资净额
-5.92%-7.29M
1386.32%64.14M
-15.33%-8.32M
3.35%-6.42M
-7.37%-6.89M
32.16%-4.99M
-31269.57%-7.21M
-103.33%-6.65M
-216.43%-6.41M
-2541.86%-7.35M
-100.78%-23.00K
4751.33%199.88M
-160.49%-2.03M
-96.88%301.00K
210.71%2.93M
500.58%4.12M
190.89%3.35M
3121.40%9.63M
304.72%943.00K
-78.74%686.00K

常见问题

Enanta Pharmaceuticals Inc的总收入是多少?

根据Enanta Pharmaceuticals Inc的FY2025财报,总收入达到了65.32M(同比变化67.64M)。

Enanta Pharmaceuticals Inc的流动资产是多少?

根据Enanta Pharmaceuticals Inc的FY2025财报,流动资产为204.34M(同比变化-31.85)。

Enanta Pharmaceuticals Inc的总资产是多少?

根据Enanta Pharmaceuticals Inc的FY2025财报,Enanta Pharmaceuticals Inc的总资产为280.73M(同比变化-25.47)。

Enanta Pharmaceuticals Inc的总负债是多少?

根据Enanta Pharmaceuticals Inc的FY2025财报,Enanta Pharmaceuticals Inc的总负债为216.01M(同比变化-12.84)。

Enanta Pharmaceuticals Inc的总权益是多少?

根据Enanta Pharmaceuticals Inc的FY2025财报,Enanta Pharmaceuticals Inc的总权益为64.72M(同比变化-49.76)。

Enanta Pharmaceuticals Inc的净营业收入是多少?

根据Enanta Pharmaceuticals Inc的FY2025财报,Enanta Pharmaceuticals Inc的净营业收入为-85.35M(同比变化29.86)。

Enanta Pharmaceuticals Inc的净投资是多少?

根据Enanta Pharmaceuticals Inc的FY2025财报,Enanta Pharmaceuticals Inc的净投资为40.35M(同比变化-30.72)。

Enanta Pharmaceuticals Inc的净融资是多少?

根据Enanta Pharmaceuticals Inc的FY2025财报,Enanta Pharmaceuticals Inc的净融资为-26.62M(同比变化3.65)。

Enanta Pharmaceuticals Inc的每股收益(EPS)是多少?

根据Enanta Pharmaceuticals Inc的FY2025财报,每股收益(EPS)为-3.84(同比变化30.03)。

Enanta Pharmaceuticals Inc的净利润是多少?

根据Enanta Pharmaceuticals Inc的FY2025财报,净利润为-81.89M(同比变化29.43)。

Enanta Pharmaceuticals Inc的净利润率是多少?

根据Enanta Pharmaceuticals Inc的FY2025财报,净利润率为-125.36(同比变化26.94)。

Enanta Pharmaceuticals Inc的债务与资产比率是多少?

根据Enanta Pharmaceuticals Inc的FY2025财报,债务与资产比率为50.99(同比变化14127.10)。

Enanta Pharmaceuticals Inc的股东权益回报率(ROE)是多少?

根据Enanta Pharmaceuticals Inc的FY2025财报,股东权益回报率(ROE)为-84.63(同比变化-26.00)。

Enanta Pharmaceuticals Inc的资产回报率(ROA)是多少?

根据Enanta Pharmaceuticals Inc的FY2025财报,资产回报率(ROA)为-24.91(同比变化9.95)。

Enanta Pharmaceuticals Inc的营业利润是多少?

根据Enanta Pharmaceuticals Inc的FY2025财报,营业利润为-85.35M(同比变化29.86)。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有